Financial incentives motivates doctors to reduce ethnic differences in heart disease treatments
If you’re a cancer cell, you want a protein called Bcl-2 on your side because it decides if you live or die. It’s usually a trusted bodyguard, protecting cancer cells from programmed death and allowing them to grow and form tumors. But sometimes it turns into their assassin. Scientists knew it happened, but they didn’t
Full Post: Scientists develop peptide that converts Bcl-2 protein from a cancer cell’s friend to a foe
Financial incentives for doctors can improve the management of coronary heart disease (CHD) and reduce ethnic differences in quality of and access to care, according to Dr. Christopher Millett, Consultant in Public Health at Imperial College Faculty of Medicine in London in the UK, and his colleagues.
Their evaluation of the benefits of pay for performance schemes in the UK for the management of coronary heart disease, with a particular focus on ethnic differences, has just been published online in Springer’s Journal of General Internal Medicine.
Pay for performance incentive schemes were introduced by the National Health Service in the UK in April 2004, to improve the quality of healthcare for all patients. The new family practitioner contract stated that 25 percent of a doctor’s income would depend on performance against targets.
It is well documented that there are marked differences in cardiovascular disease prevalence and subsequent health outcomes between ethnic groups, as well as potential unequal access to high-quality care. The authors looked at whether financial incentives for doctors would address these differences in management of CHD across ethnic groups.
Millett and his team looked at electronic records from 32 family practices in inner city London, before and after the introduction of the new contract in 2004. They identified 2,891 people with CHD in 2003 and 3,101 in 2005 and examined 10 quality indicators for CHD management. There were incentives for recording smoking status, measuring cholesterol and blood pressure, prescribing aspirin, beta-blockers and ACE inhibitors, as well as for controlling cholesterol and blood pressure. There were no incentives for either BMI measurement or prescription of statins.
Millett and his team found that more patients were reaching national treatment targets for both blood pressure and total cholesterol since the implementation of the pay for performance initiative in April 2004. The scheme improved CHD management across both incentivized and non-incentivized indicators. There were also fewer differences in prescribing and clinical outcomes between ethnic groups in 2005 than in 2003. For example, improvements in blood pressure control were greater in the black group than amongst the whites over the two year period, with the treatment gap between the two groups closing between 2003 and 2005. More South Asians also had their blood pressure recorded in 2005 than in 2003. However, black patients were still less likely to be prescribed statins than South Asians or whites in 2005.
The authors conclude that “whilst the management of CHD remains suboptimal in many patients, improvements in the quality of care seen since the new contract are impressive?.most patients, including those from ethnic minority groups and living in areas of low socio-economic status, appear to have benefited from the scheme.” They add that healthcare planners in other countries may want to consider introducing similar initiatives for their own primary care physicians.
People from black and south Asian communities in the UK are not benefiting as much as white people from doctors’ interventions to reduce their blood pressure, according to a new study published today in the journal Annals of Family Medicine. The study looked at the treatment of over 8,800 people with high blood pressure, visiting
Full Post: Black and south Asian people benefiting less from interventions to reduce blood pressure
The initial evaluation and management of injured patients from minority ethnic groups nationwide appears to be similar to that of non-Hispanic white patients, according to a report in the November issue of Archives of Surgery. “Ethnic disparities in our health care system have been well documented in treatment of several diseases, such as coronary artery
Full Post: Ethnic disparities in treatment of trauma patients
The proportion of white children with high hopes for their educational progress is much lower than for other ethnic groups in England. One of the key factors behind the difference is parents’ aspirations for their children. These are the findings of new research by Professor Simon Burgess and Dr Deborah Wilson of the Centre for Market
Full Post: White children have lower educational aspirations than most ethnic minorities
Racial disparity in the control of hypertension contributes to the deaths of almost 8,000 black men and women in the United States annually, according to a first-of-its-kind study published today in the Annals of Family Medicine by University of Rochester Medical Center researchers. The researchers concluded that the deaths could be avoided or postponed if
Full Post: Blood pressure control inequality linked to deaths among blacks
More than half of people diagnosed with high blood pressure do not have it under control and many more go undiagnosed, according to research carried out at the University of Warwick. Professor Franco Cappuccio from Warwick Medical School at the University of Warwick led the only UK team to participate in a European study examining
Full Post: High blood pressure a looming problem for Europe